PMC:7299399 / 14408-14955
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T68 | 49-56 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T85 | 0-9 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T86 | 49-56 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T87 | 186-196 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T88 | 325-330 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T89 | 424-439 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T90 | 424-433 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T91 | 434-439 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T69 | 390-486 | Sentence | denotes | For these reasons, when designing antiviral drugs, clearance mechanisms have to be kept in mind. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 238 | 87-91 | Gene | denotes | ACE2 | Gene:59272 |
| 239 | 41-42 | Gene | denotes | S | Gene:43740568 |
| 240 | 43-48 | Gene | denotes | spike | Gene:43740568 |
| 242 | 277-285 | Species | denotes | patients | Tax:9606 |
| 244 | 255-263 | Disease | denotes | toxicity | MESH:D064420 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-32015507-158478 | 101-103 | 32015507 | denotes | 19 |
| 32519842-32333836-158479 | 104-106 | 32333836 | denotes | 21 |
| 32519842-32142651-158480 | 107-109 | 32142651 | denotes | 23 |